Introduction
Based on several lines of evidence, this laboratory has formulated a hypothesis to explain the acute and chronic ototoxic actions of aminoglycosides in the inner ear [16, 20, 21] . In the course of their action, the aminoglycosides appear to occupy at least two different cellular compartments.
Perilymphatic perfusions of the guinea pig cochlea with gentamicin reduced the cochlear microphonic potential (CM) with an initial acute phase that was readily reversed by the addition of calcium; this was followed by a second phase insensitive to calcium [23] . Pharmacokinetic data demonstrated two different half-lives of gentamicin in cochlear tissues prior to and after the onset of chronic toxicity [25] . Consistent with these data would be a binding of gentamicin to the external cell surface as a first step (first compartment) and binding to intracellular components such as polyphos- 
Materials and Methods

Experiments
were performed on male guinea pigs (Hartley) weighing 250-400 g. Surgical and perilymphatic perfusion techniques were essentially as previously described [16, 17, 23 ]. An animal with a positive Preyer reflex was anesthetized with sodium pentobarbital (20 mg/kg body wt.. i.p.), atropine sulfate (0.05 mg/kg body wt., s.c.) and Innovar (0.5 ml/kg body wt., i.m. containing 0.4 mg fentanyl and 20 mg droperidol/ml). Rectal temperature was maintained at 37 t-l°C with a heating pad and artificial respiration provided through a tracheal cannula.
The EP was measured with a 3 M KC1 microelectrode inserted through the spiral ligament of the basal turn [14] . Perilymphatic perfusions were performed via glass capillaries implanted into the basal turn of Scala tympani and Scala vestibuli. The perfusion pipettes were placed prior to insertion of the EP recording electrode. The flow of perfusate was initiated after establishing a stable, positive EP. The CM was measured from a recording electrode in the Scala tympani perfusion pipette and a reference electrode in the superficial masseter muscle. The CM was recorded in response to a sound stimulus of white noise, 20-4000 Hz, delivered to the external auditory meatus through an earphone coupled to an ear speculum. The sound intensity was adjusted to approximately 70 dB SPL to give an initial CM of 200-400 nV (RMS). Perilymphatic spaces were perfused at a rate of approximately 30 pl/min with artificial perilymph containing 130 mM NaCl, 5 mM KU, 1 mM CaCl,, 2 mM MgCl,, 0.1 mM NaH,PO,, 10 mM NaHCO,, 5 mM glucose and 10 mM Hepes, final pH, 7.4. Gentamicin sulfate was dissolved in the artificial perilymph at a concentration of 10 mM and the pH adjusted with NaOH. After CM and EP had stabilized for 30 min the 'control perfusate' was switched to the 'experimental perfusate' containing drug. Gentamicin was perfused for 5 min whereafter perfusion with the control perfusate was resumed. Experiments were usually carried out for 90-120 min but perfusions without drugs could be extended for up to 3 h without major (< 20%) loss of CM. Animals with an initial CM of less than 200 PV or with an unstable CM and EP during the control period (loss of > 10%) were eliminated from the study. Amino-oxyacetic acid (10 mM) was dissolved in artificial perilymph and the pH adjusted with NaOH. Furosemide (50 mg/kg body weight) was injected over 90 s intravenously via a catheter in the left jugular vein. Anoxia was induced by shutting off the respirator. Furosemide and aminooxyacetic acid (AOAA) were purchased from Sigma. Gentamicin sulfate was a gift from the Schering Corporation (Bloomfield, NJ).
Results
Gentamicin
at a concentration of 10 mM perfused as a bolus through the perilymphatic space for 5 min drastically reduced the microphonic potential but had no effect on the endolymphatic potential ( Fig. 1 and Table I ). The CM began to decline rapidly within 30 s after gentamicin entered the cochlea and continued to decline, although after the 5 min perfusion the perfusate no longer contained the drug. Consistently, a 60% reduction of CM was reached after 60 min. This irreversible action of gentamicin on CM and its lack of effect on EP have been described before [12, 13] .
Anoxia induced by turning the respirator off produced a rapid decline in EP and CM (Fig. 2) . This effect rapidly and completely reversed if the respirator was turned back on after 3 min ( Fig. 2 and Table I ). One hour after anoxia plus gentamicin. CM had recovered to 97 & 6% of its pre-drug control value (Table I) whereas one hour after gentamicin alone. CM was 40 & 2% of its pre-drug value (Table I) .
Following intravenous injections of a bolus of furosemide (50 mg/kg), the endolymphatic potentials fell rapidly to near zero values (Fig. 3) . The peak suppression of EP and CM occurred in less than 2 min. This was followed by a quick recovery of EP by about 20-30 mV, a plateau and then a gradual recovery to pre-injection values (Fig. 3) . The CM followed a similar time course of recovery was changed at the point indrcated for 5 mm to experimental perfusate containing 10 mM gentamicin (Cm). Curves are mean values from 4 animals (EP) and 5 animals (CM). Note the lack of effect of gentamicin on the EP. Ml--J--J 0 I 2 3 4 5 6 7 6 9 IO 20 TIME (Inin) Fig. 2 . Prevention of gentamicin-induced suppression of cochlear microphonic potentials during anoxic reduction of the endolymphatic potential. Experimental procedures were carried out as described in Materials and Methods. Following the control perfusion for 30 min the respirator was turned off at the time indicated by the arrow. 90 s later the control perfusate was changed to experimental perfusate containing 10 mM gentamicin (GM) for 5 min. Bar indicates time that gentamicin was in the perilymphatic space. After 3 min of asphyxia the respirator was turned back on. Thus. CM and EP were markedly reduced by anoxia at the time gentamicin entered the cochlea and remained suppressed for at least 2 of the 5 min of exposure to the drug. -, perfusions without gentamicin;
-----.
perfusions with gentamicin. Note that in contrast to results shown in Fig. 1 the CM recovers to pre-drug values. and returned to 102 k 8% of its initial value by 90 min (Table I) . These results, again, are compatible with previous reports by others [19] . The actions of 10 mM gentamicin were prevented when the 5 min perfusion of gentamicin was initiated at the time of peak suppression of EP by furosemide ( Fig. 3  and ------. with gentamicin. Again, note that in contrast to results shown in Fig. 1 the CM recovers to pre-gentamicin values.
CM had recovered to 107 + 8% of its initial value by 90 min (Table I) . Perilymphatic perfusion of 10 mM AOAA rapidly suppressed EP and CM (Fig. 4) . The effects of AOAA were reversible but required prolonged periods of perfusion with drug-free perfusate: by 60 min, CM had only recovered to 72 i 7%' of pre-AOAA values (Table I) . These effects of AOAA on cochlear potentials are in keeping with reports of others [2, 3] . The actions of 10 mM gentamicin on CM were prevented if the 5 min gentamicin perfusion began at the time of maximal EP and CM suppression (Fig. 4 and Table I ) by AOAA. In contrast, if the administration of gentamicin preceded the perfusion of AOAA there was little, if any, recovery of CM after 60 min when compared to perfusions of gentamicin alone (Table I) .
Discussion
The salient finding is that the expression of gentamicin toxicity requires an active metabolic process. This is the broadest interpretation of the fact that gentamicin toxicity is prevented when the drug is administered during a period of decreased endolymphatic potential. In this context the reduction of EP is taken as an indicator of interference with energy metabolism in cochlear structures. The question then arises what this active metabolic process is and how it affects the mechanism of aminoglycoside toxicity. First we may consider the uptake of the drug. In the mechanism of the antibacterial activity of aminoglycosides it is clearly established that an active uptake process precedes the toxic effect of the drug [lo] and uptake into the kidney also has an energy-dependent component [l] . For the inner ear such evidence still is lacking but results presented here are compatible with an active drug uptake system in the inner ear. When inhibited by such manipulations as asphyxia. the drug would not penetrate the cells and thus not be toxic.
The nature of the cochlear uptake system cannot be delineated from the present study. A target-specific inhibition of a transport system seems unlikely since such diverse agents as asphyxia. furosemide, and aminooxyacetic acid all produced a similar effect. Rather, since all agents used inhibit metabolism as indicated by the de
